Anuncio
Anuncio
IKT
Inhibikase Therapeutics, Inc. Common Stock
1.62
USDPatrocinado
+0.05
+3.18%
28 oct, 15:59 UTC -4
Cerrado
Post-mercado
1.63
0.00
+0.31%
Inhibikase Therapeutics, Inc. Common Stock (IKT)
Panorámica financiera de Inhibikase Therapeutics, Inc. Common Stock
| Capitalización de mercado | 226.75M |
| Beta | -- |
| Beneficios por acción (EPS) | -0.43 |
| Relación Precio/Valor contable (P/B) | -- |
| Margen operativo | -- |
| Deuda total/Capital (D/E) | 0.00% |
| Relación P/E | -- |
| Retorno sobre el capital (ROE) | -- |
| Razón corriente | 15.82% |
| Flujo de caja libre | -24.50M |
